01 Aug, EOD - Indian

Nifty Pharma 22011.7 (-3.33)

Nifty Smallcap 100 17668.2 (-1.66)

Nifty 50 24565.35 (-0.82)

Nifty IT 34649.6 (-1.85)

Nifty Midcap 100 56637.15 (-1.33)

SENSEX 80599.91 (-0.72)

Nifty Next 50 66192.8 (-1.35)

Nifty Bank 55617.6 (-0.62)

01 Aug, EOD - Global

NIKKEI 225 40799.6 (-0.66)

HANG SENG 24507.81 (-1.07)

S&P 6275.25 (-1.74)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoUnjha Formulations Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 531762 | NSE Symbol : | ISIN : INE576D01015 | Industry : Pharmaceuticals - Indian - Formulations |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
22-Apr-2025 16-May-2025 Accounts Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve Clause 29(1)(a)of SEBI(LODR) Regulation 2015 Regu 33 of LODR Regulation 2015 APPOINTMENT OF SECRERTRAILA AUDITORS Appointment of secretarial Auditors (As Per BSE Announcement Dated on 16.05.2025) Regulation 33(3) of SEBI (LODR) Regulations 2015. (As Per BSE Announcement Dated on 19.05.2025)
11-Mar-2025 17-Mar-2025 Others Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/03/2025 inter alia to consider and approve Clause 29(1)(a) of SEBI LODR Regulations 2015
16-Jan-2025 04-Feb-2025 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve REGU 29(1)(a) of Listing Agrement Regulation 33 of SEBI (LODR) 2015 (As Per BSE Announcement dated on 04.02.2025)
16-Oct-2024 08-Nov-2024 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve Regulation 29(1)a of Listing Agreement REGULATION OF 33 OF SEBI (LODR) 2015 (As Per BSE Announcement dated on 08.11.2024)
19-Jul-2024 01-Aug-2024 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve Clause 29(1)(a) of Listing Agreement REGU 33 OF SEBI ( LODR) Act 2015 (As per BSE Announcement Dated on 01/08/2024)
08-May-2024 17-May-2024 Accounts UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve AS PER CLAUSE 29(1)(a)OF SEBI (LODR) REGULATIONS 2015. Intimation of Board Meeting Regulation 3 of SEBI(LODR) Regulations.2015. (As Per BSE Announcement Dated on 17.05.2024)
26-Mar-2024 29-Mar-2024 Others UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Obligation and Disclosure Requirement) Regulations2015. Intimation of Board Meeting as per SEBI (LODR) Regu 2015 (As Per BSE Announcement dated on 29.03.2024)
18-Jan-2024 29-Jan-2024 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Ref : Clause 29(a) of Listing Agreement REGU 33 OF SEBI ( LODR) 2015 Regulation 33 of SEBI(LODR) 2015. (As per BSE Announcement Dated on 29/01/2024)
23-Oct-2023 09-Nov-2023 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve Regu 29(1)(a) of Listing Agreement Regulation 33 of SEBI(LODR) Regulations 2015 (As per BSE Announcement Dated on 09/11/2023) Regulation 33(3) of SEBI (LODR) Act 2015 (As Per BSE Announcement Dated on 29/11/2023)
03-Oct-2023 03-Oct-2023 Change in Auditors Resignation of Statutory Auditors Appointment of Statutory Auditors on casual vacancy caused
13-Jul-2023 04-Aug-2023 Quarterly Results Cl.29 91)(a) of Listing Agreement Intimation of Board Meeting as per Regu 33 of SEBI(LODR) Regulations ,2015. Intimation of Board Meeting under Regu. 33 of SEBI(LODR) REGULATIONS ,2015. (As per BSE Announcement Dated on 04/08/2023)
17-Apr-2023 10-May-2023 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Obligation and Disclosure Requirement) Regulations2015 Intimation of Board Meeting as per Regu. 33 of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR under Regulation 30 of SEBI (As Per BSE Announcement Dated on 10.05.2023)
20-Mar-2023 27-Mar-2023 Others UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2023 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Obligation and Disclosure Requirement) Regulations2015. Intimation of Board Meeting as per Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR) (As Per BSE Announcement Dated on 27.03.2023)
12-Jan-2023 10-Feb-2023 Accounts UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Ref: Clause 29(1)(a) of the Listing Agreement Intimation of Board Meeting as per Regulation. 33 of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR) (As per BSE Announcement Dated on 10/02/2023)
17-Oct-2022 10-Nov-2022 Quarterly Results UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve Ref: Clause 29(1)(a) of the Listing Agreement : Intimation of Board Meeting as per Regu. 33 of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR) Ref: Intimation of Board Meeting as per Regu. 33 of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR) (As per BSE Announcement Dated on 10/11/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-8657545825
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
subscription@capitalmarket.com

For Capital Market Online Product related queries :
financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +